» Authors » Stephen M Schwartz

Stephen M Schwartz

Explore the profile of Stephen M Schwartz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 293
Citations 18932
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ugalde-Morales E, Wilf R, Pluta J, Ploner A, Fan M, Damra M, et al.
Am J Hum Genet . 2025 Feb; 112(3):630-643. PMID: 39999848
Transcriptome-wide association studies (TWASs) have the potential to identify susceptibility genes associated with testicular germ cell tumors (TGCTs). We conducted a comprehensive TGCT TWAS by integrating genome-wide association study (GWAS)...
2.
Chow E, Blythe N, Cushing-Haugen K, Duggan C, Baker K, Cole A, et al.
J Cancer Surviv . 2025 Feb; PMID: 39955465
Purpose: Assess the feasibility, acceptability, and preliminary efficacy of lay health educators to enhance Hispanic/Latino survivors' knowledge of their cancer history, screening needs, and health-related self-efficacy. Methods: Hispanic/Latino survivors diagnosed...
3.
Karvonen K, Doody D, Barry D, Bona K, Winestone L, Rosenberg A, et al.
Cancer . 2025 Jan; 131(3):e35677. PMID: 39866001
Background: Historical redlining has been associated with inferior survival in adult-onset cancers. However, its relationship with pediatric, adolescent, and young-adult-onset cancer outcomes is unknown. Methods: This study identified incident cancer...
4.
McDougall J, Briant K, Carosso E, Cole A, Dee C, Doody D, et al.
Prev Oncol Epidemiol . 2025 Jan; 2(1). PMID: 39760096
In 2022, the catchment area of the Fred Hutchinson/University of Washington/Seattle Children's Cancer Consortium (the Consortium) grew from 13-counties in Western Washington State to include all 39 counties in Washington....
5.
Mukand N, Chirikova E, Lichtensztajn D, Negoita S, Aboushwareb T, Bennett J, et al.
Cancer . 2024 Aug; 130(24):4298-4305. PMID: 39158464
Background: The Oncotype DX Genomic Prostate Score (ODX-GPS) is a gene expression assay that predicts disease aggressiveness. The objective of this study was to identify sociodemographic and regional factors associated...
6.
Petkov V, Byun J, Ward K, Schussler N, Archer N, Bentler S, et al.
J Natl Cancer Inst Monogr . 2024 Aug; 2024(65):168-179. PMID: 39102888
Background: Precision medicine has become a mainstay of cancer care in recent years. The National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) Program has been an authoritative source...
7.
Zhang M, Chen C, Li G, Koric A, Lee Y, Morgenstern H, et al.
Cancer Med . 2024 Feb; 13(3):e7019. PMID: 38400665
Background: Cocaine is an illegal recreational drug used worldwide, yet little is known about whether cocaine inhalation (smoking/snorting) increases the risk of head and neck cancer (HNC). Methods: The analyses...
8.
Warren J, Mariotto A, Stevens J, Davidoff A, Shankaran V, Ward K, et al.
J Clin Oncol . 2024 Feb; 42(9):1001-1010. PMID: 38320222
Purpose: This study assessed the prevalence of specific major adverse financial events (AFEs)-bankruptcies, liens, and evictions-before a cancer diagnosis and their association with later-stage cancer at diagnosis. Methods: Patients age...
9.
Schwartz S
Clin Chem . 2024 Jan; 70(1):140-149. PMID: 38175589
Background: Cancers are a large and heterogeneous group of malignant tumors that collectively accounted for approximately 600 000 US deaths in 2020; only heart disease claimed more lives. A large...
10.
Chtourou A, Sanchez P, Golden T, Chen H, Schwartz S, Wu X, et al.
Cancer Epidemiol Biomarkers Prev . 2023 Aug; 32(11):1591-1598. PMID: 37594474
Introduction: Health care procedures including cancer screening and diagnosis were interrupted due to the COVID-19 pandemic. The extent of this impact on cancer care in the United States is not...